Jun Huang
Peking University Institute of Hematology · Peking University People's Hospital · 6th Affliated Hospital of Sun Yat-sen University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jun Huang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:20 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07919470 · Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCTPeking University People's Hospital · not yet recruiting · Acute Lymphoblastic Leukemia, Hematopoietic Stem Cell Transplantation · principal investigator
- N/ANCT07869342 · NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Controlled StudyPeking University People's Hospital · not yet recruiting · Acute Myeloid Leukemia, Adult · principal investigator
- Ph2NCT07765667 · NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARCSixth Affiliated Hospital, Sun Yat-sen University · not yet recruiting · Rectal Adenocarcinoma, High-Risk Cancer, MSS · study chair
- Ph2NCT07677306 · Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCTPeking University People's Hospital · recruiting · Myelodysplastic Syndromes · principal investigator
- Ph3NCT07549399 · SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RCSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Rectal Adenocarcinoma, High-Risk Cancer, MSS · principal investigator
- Ph2NCT07381309 · Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLMJun Huang · not yet recruiting · CRC, Liver Metastasis Colon Cancer · principal investigator
- N/ANCT07038122 · Reducing the Resection Range After Neoadjuvant Therapy for Locally Advanced Upper Rectal and Rectosigmoid Junction CancersSixth Affiliated Hospital, Sun Yat-sen University · active not recruiting · Locally Advanced Rectal Carcinoma · principal investigator
- Ph3NCT06998758 · Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRCSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Neoadjuvant Chemotherapy, Weight Loss · principal investigator
- Ph1/Ph2NCT06880913 · Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALLPeking University People's Hospital · recruiting · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma · principal investigator
- Ph3NCT06794086 · SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver MetastasesJun Huang · recruiting · Colorectal Cancer, Liver Metastases · principal investigator
- Ph3NCT06791512 · mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRCJun Huang · recruiting · Colorectal Cancer (CRC), pMMR/MSS Adenocarcinoma of the Colon or Rectum · principal investigator
- Ph2NCT06767007 · SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE)Sixth Affiliated Hospital, Sun Yat-sen University · recruiting · Unresectable Locally Recurrent Rectal Cancer · principal investigator
- N/ANCT06512545 · Modified Second Haplo-transplantation for Graft FailurePeking University People's Hospital · recruiting · Graft Failure, Stem Cell Transplant Complications · principal investigator
- N/ANCT06512519 · Second Haplo-transplantation for Graft FailurePeking University People's Hospital · recruiting · Graft Failure, Stem Cell Transplant Complications · principal investigator
- Ph2NCT06364384 · Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell CarcinomaSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Rectal Squamous Cell Carcinoma · principal investigator
- N/ANCT06364371 · Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal CancerSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Predictive Cancer Model, Pathologic Complete Response · principal investigator
- Ph1/Ph2NCT06279494 · Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin InhibitorsPeking University People's Hospital · unknown · Acute Leukemia, Myelodysplastic Syndromes, Severe Aplastic Anemia · principal investigator
- N/ANCT06211166 · Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain ReactionPeking University People's Hospital · recruiting · Acute Leukemia, MDS, MDS/MPN · principal investigator
- Ph4NCT06069180 · The Optimization of Conditioning Regimen for HLA Matched HSCT in SAAPeking University People's Hospital · unknown · Severe Aplastic Anemia · principal investigator
- Ph2NCT06024031 · NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After ChemotherapyPeking University People's Hospital · active not recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT05953662 · Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal CancerSixth Affiliated Hospital, Sun Yat-sen University · active not recruiting · Colorectal Neoplasm · principal investigator
- N/ANCT05943444 · Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal CancerSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Rectal Neoplasms, Low Anterior Resection Syndrome, Anastomotic Leak · principal investigator
- Ph3NCT04960644 · MTX and Steroid as First-line Therapy for aGVHDPeking University People's Hospital · completed · Acute GVH Disease · principal investigator
- Ph2NCT04958538 · MTX and Steroid for III-IV aGVHD TreatmentPeking University People's Hospital · unknown · Acute Graft Versus Host Disease · principal investigator
- Ph2NCT04895137 · mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRCSixth Affiliated Hospital, Sun Yat-sen University · completed · Colorectal Cancer, Immunotherapy · principal investigator
- Ph2NCT04677868 · MTX and Steroid for aGVHD TreatmentPeking University People's Hospital · unknown · Acute GVH Disease · principal investigator
- N/ANCT04643041 · Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal CancerSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Rectal Cancer · study chair
- Ph1NCT04221971 · NK Cell Infusion for Patients With Acute Myeloid LeukemiaPeking University People's Hospital · unknown · Acute Myeloid Leukemia · principal investigator
- Ph3NCT04175587 · Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APLPeking University People's Hospital · unknown · Acute Promyelocytic Leukaemia · principal investigator
- Ph3NCT03967665 · Risk Stratification-directed NAC for Prevention of Poor Hematopoietic ReconstitutionPeking University People's Hospital · unknown · Stem Cell Transplant Complications · principal investigator
- Ph2/Ph3NCT03799224 · Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute LeukemiaPeking University People's Hospital · unknown · Stem Cell Transplant Complications, Relapse Leukemia, Refractory Leukemia · study chair
- Ph2/Ph3NCT03793517 · Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCTPeking University People's Hospital · unknown · Stem Cell Transplant Complications, Leukemia, Myeloid, Acute, Leukemia Relapse · study chair
- N/ANCT03756675 · Haploidentical Peripheral Blood Stem Cell Transplantation for Acute LeukemiaPeking University People's Hospital · unknown · Acute Leukemia · principal investigator
- N/ANCT03748485 · Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 DiagnosisSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Colorectal Cancer, Adjuvant Chemotherapy · study chair
- N/ANCT03672084 · Allo-HSCT as First-line Consolidation in High-risk PTCLPeking University People's Hospital · unknown · T Cell Lymphoma · principal investigator
- Ph2NCT03412409 · RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCTPeking University People's Hospital · unknown · Acute Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph2NCT03412266 · RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCTPeking University People's Hospital · unknown · Myelodysplastic Syndromes · principal investigator
- Ph2/Ph3NCT03391856 · Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive TherapyPeking University People's Hospital · terminated · Thrombocytopenia, Stem Cell Transplant Complications · principal investigator
- Ph2NCT03297528 · Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After AllotransplantPeking University People's Hospital · unknown · Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation, Acute Leukemia · study director
- Ph2NCT03236220 · Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell TransplantationPeking University People's Hospital · completed · Haploidentical Hematopoietic Stem Cell Transplantation · principal investigator
- Ph1/Ph2NCT02985775 · Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post TransplantationPeking University People's Hospital · completed · CMV Infection · principal investigator
- N/ANCT02757586 · Treatment of Chronic Lymphocytic LeukemiaPeking University People's Hospital · unknown · Leukemia, Lymphocytic, Chronic, B-Cell · principal investigator
- Ph2NCT02757196 · Treatment of ITP With Rituximab and / or AccutanePeking University People's Hospital · unknown · Immune Thrombocytopenia · study chair
- Ph3NCT02757040 · Combination of Ibrutinib and As2O3 in the Treatment of CLLPeking University People's Hospital · unknown · Leukemia, Lymphocytic, Chronic, B-Cell · principal investigator
- Ph1/Ph2NCT02568241 · Interferon-α After DLI for the Prevention of RelapsePeking University People's Hospital · unknown · Leukemia · principal investigator
- N/ANCT02185261 · Interferon α for the Therapy of Minimal Residual DiseasePeking University People's Hospital · unknown · Leukemia · principal investigator
- Ph3NCT02042690 · Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia PatientsPeking University · completed · Acute Lymphoblastic Leukemia · principal investigator
- N/ANCT01617473 · Randomized Trial of Mobilized Blood/Marrow Versus Blood TransplantPeking University People's Hospital · withdrawn · Leukemia · principal investigator
- N/ANCT00460330 · Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCTPeking University · unknown · Invasive Fungal Infection, Aspergillosis, Fungemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 29 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:20 UTC. The ranking covers the 200 most relevant of 35 PubMed records, and a shared surname and initials can bring in a namesake. All 35 on PubMed
- Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.Clin Cancer Res · 2013198 citationsRCR 5.0
- Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation.Cell Metab · 2024156 citationsRCR 16.5
- Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.Br J Cancer · 201665 citationsRCR 2.1
- Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.Clin Colorectal Cancer · 201441 citationsRCR 1.0
- 40 citationsRCR 2.8
- CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial.BMC Cancer · 201826 citationsRCR 1.0
- NIBP impacts on the expression of E-cadherin, CD44 and vimentin in colon cancer via the NF-κB pathway.Mol Med Rep · 201625 citationsRCR 0.8
- Endoscopic mucosal resection with circumferential incision for treatment of rectal carcinoid tumours.World J Surg Oncol · 201423 citationsRCR 1.1
- Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.J Cell Biochem · 201919 citationsRCR 0.6
- Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials.Cancer Commun (Lond) · 202517 citationsRCR 2.7